Goldman Sachs’s Core Scientific CORZ Stock Holding History

Goldman Sachs’s Portfolio CORZ Stock Details CORZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$78.5M	Buy	3,068,145 +513,011	+20%	+$12.1M	0.01%	1419
2026 Q1	$38.2M	Sell	2,555,134 -250,405	-9%	-$4.27M	﹤0.01%	1798
2025 Q4	$40.8M	Buy	2,805,539 +23,941	+0.9%	+$417K	0.01%	1681
2025 Q3	$49.9M	Buy	2,781,598 +1,764,502	+173%	+$25.9M	0.01%	1420
2025 Q2	$17.4M	Sell	1,017,096 -1,005,906	-50%	-$10.1M	﹤0.01%	2255
2025 Q1	$14.6M	Sell	2,023,002 -216,033	-10%	-$2.46M	﹤0.01%	2326
2024 Q4	$31.5M	Buy	2,239,035 +972,638	+77%	+$14.4M	0.01%	1705
2024 Q3	$15M	Buy	1,266,397 +175,403	+16%	+$1.82M	﹤0.01%	2314
2024 Q2	$10.1M	Buy	+1,090,994	New	+$5.57M	﹤0.01%	2491

Other funds holding CORZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return

Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

VARA

Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return

Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return

Goldman Sachs's CORZ Position: Q2 2026 in Review

Goldman Sachs increased its Core Scientific (CORZ) stake by 20% in Q2 2026, buying an estimated $12.1M and bringing the position to 3,068,145 shares worth $78.5M. The position accounts for 0.01% of the portfolio, ranked #1419.

Goldman Sachs first reported a position in CORZ in Q2 2024 and has held it in 9 quarters since. 415 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

Goldman Sachs held 3,068,145 shares of Core Scientific worth $78.5M as of Q2 2026.
Goldman Sachs bought 513,011 Core Scientific shares in Q2 2026, an estimated $12.1M.
Core Scientific made up 0.01% of Goldman Sachs's portfolio in Q2 2026, its #1419 holding.
Goldman Sachs first reported a position in Core Scientific in Q2 2024 and has held it in 9 quarters since.
415 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.